|
|
||||||||
Department of Radiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
Correspondence: For correspondence or reprints contact: William T. Phillips, MD, Radiology Department, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7800.
ABSTRACT
This study evaluated two 99mTc-liposome formulations as potential blood-pool agents in comparison with standard 99mTc-red cells and 99mTc-human serum albumin (HSA). Methods: Liposomes with no surface modification or coated with polyethylene glycol (PEG) were labeled with 99mTc using the lipophilic chelator, HMPAO. Autologous red cells were labeled with 99mTc using in vitro or in vivo techniques. Technetium-99m-HSA was supplied commercially. Rabbits were injected intravenously with 99mTc-liposomes, 99mTc-red cells or 99mTc-HSA. Static images were acquired and blood samples collected. Results: Technetium-99m-liposome images showed prominent blood-pool activity compared to lung and liver activities, which were similar to those acquired for 99mTc-red cells, but better than 99mTc-HSA. Heart-to-lung ratios were not significantly different between 99mTc-liposome formulations or for either formulation compared to 99mTc-red cells. The ratios were higher, however, than for 99mTc-HSA. Heart-to-liver ratios were higher for PEG 99mTc-liposomes than they were for neutral 99mTc-liposomes and 99mTc-HSA, but were not significantly different than 99mTc-red cells. Bladder activities for both 99mTc-liposome formulations were 36 times lower than for the other agents. PEG 99mTc-liposomes remained in circulation 1.6 times longer than any of the other agents. Conclusions: Technetium-99m-liposomes, independent of surface modification, had excellent circulation persistence and in vivo stability when compared to 99mTc-red cells and 99mTc-HSA. PEG 99mTc-liposomes performed better than neutral 99mTc-liposomes due to lower liver background activity. Advantages of PEG 99mTc-liposomes compared to 99mTc-red cells include: (a) only one venipuncture, (b) little exposure to patient's blood, (c) excellent in vitro and in vivo stability and (d) lack of drug interference.
Key Words: liposomes technetium-99m-liposomes blood-pool imaging technetium-99m-HMPAO ventriculography polyethylene glycol
This article has been cited by other articles:
![]() |
V. D. Awasthi, D. Garcia, R. Klipper, B. A. Goins, and W. T. Phillips Neutral and Anionic Liposome-Encapsulated Hemoglobin: Effect of Postinserted Poly(ethylene glycol)-distearoylphosphatidylethanolamine on Distribution and Circulation Kinetics J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 241 - 248. [Abstract] [Full Text] |
||||
![]() |
A. Bao, B. Goins, R. Klipper, G. Negrete, and W. T. Phillips 186Re-Liposome Labeling Using 186Re-SNS/S Complexes: In Vitro Stability, Imaging, and Biodistribution in Rats J. Nucl. Med., December 1, 2003; 44(12): 1992 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Moghimi, A. C. Hunter, and J. C. Murray Long-Circulating and Target-Specific Nanoparticles: Theory to Practice Pharmacol. Rev., June 1, 2001; 53(2): 283 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Emfietzoglou, K. Kostarelos, and G. Sgouros An Analytic Dosimetry Study for the Use of Radionuclide-Liposome Conjugates in Internal Radiotherapy J. Nucl. Med., March 1, 2001; 42(3): 499 - 504. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |